FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3858911000001102: Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21760701000001115 Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
74268301000001114 Fluocinolone acetonide 0.025% / Neomycin 0.5% ointment 30 gram en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram Is pack of Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram Has active ingredient Neomycin sulfate false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram Has active ingredient Skin anti-infective false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram Has active ingredient Neomycin false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram Has active ingredient Fluocinolone false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram Has active ingredient Fluocinolone acetonide false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram Has VMP Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram Has specific active ingredient Neomycin sulfate true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram Has specific active ingredient Fluocinolone acetonide true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Synalar N ointment (GP Pharma) 30 gram Is a True Neomycin 0.5% / Fluocinolone 0.025% ointment 30 gram Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start